Biotech
Synthego
Synthego raises $200M Series C at $1.2B valuation
3565 Haven Avenue, Redwood City, CA 94063June 29, 20241 min read
Total Raised
$200M
Valuation
$1.2B
Latest Round
Series C
Employees
200+
Synthego: Series C Funding Round
Synthego has successfully raised $200M in Series C funding, reaching a valuation of $1.2B.
Company Overview
CRISPR genome engineering tools
Funding Details
The Series C round was led by Founders Fund, with participation from 8VC, Menlo Ventures, Paladin Capital Group, Tencent.
Company Information
- Headquarters: 3565 Haven Avenue, Redwood City, CA 94063
- Founded: 2012
- Employees: 200+
- Category: Biotech
Investment
Synthego plans to use the funds to accelerate product development, expand its team, and scale operations globally.
About the Investors
- Founders Fund: Verified investor in Series C
- 8VC: Verified investor in Series C
- Menlo Ventures: Verified investor in Series C
- Paladin Capital Group: Verified investor in Series C
- Tencent: Verified investor in Series C
Company Info
Headquarters
3565 Haven Avenue, Redwood City, CA 94063
Founded
2012
Team Size
200+
Last Round
$200M(Jun 2024)
Investors (5)
F
Founders FundLeadLead Investor
Verified investor in Series C
8
8VCInvestor
Verified investor in Series C
M
Menlo VenturesInvestor
Verified investor in Series C
P
Paladin Capital GroupInvestor
Verified investor in Series C
T
TencentInvestor
Verified investor in Series C
Share
Related Reports
Biotech
AusperBio
AusperBio Raises $73M Series B
Biotech company developing AHB-137, an antisense oligonucleotide for chronic hepatitis B treatment entering phase 2 trials
David Chen
Dec 30, 2025
0 min read•$73M Series B
Biotech
Orna Therapeutics
Orna Therapeutics Raises $251M Series B
Biotechnology company developing circular RNA therapeutics for cancer, genetic diseases, and infectious diseases
Emma Rodriguez
Oct 23, 2025
0 min read•$251M Series B
Biotech
Forge Biologics
Forge Biologics Raises $120M Series C
Gene therapy CDMO providing manufacturing and development services for AAV-based genetic medicines
Sarah Kim
Oct 23, 2025
0 min read•$120M Series C
Turn your sales ideas into reality today
Start your 14-day Pro trial today. No credit card required.
Start building for free